Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Allarity Therapeutics
(NASDAQ:ALLR)
Intraday
$0.80
0.046
[6.10%]
After-Hours
$0.80
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.80
0.046
[6.10%]
At close: May 10
$0.80
0
[0.00%]
After Hours: 7:59PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Allarity Therapeutics Stock (NASDAQ:ALLR)
Allarity Therapeutics Stock (NASDAQ: ALLR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, May 07, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
4 days ago
Allarity Therapeutics shares are trading lower after the company announced that all Series A Preferred and all variable priced warrants converted to common stock.
Benzinga Newsdesk
-
4 days ago
Allarity Therapeutics Announces that All Series A Preferred And All Variable Priced Warrants Have Converted To Common Stock; Convertible At $20/Share
Benzinga Newsdesk
-
4 days ago
Monday, May 06, 2024
Allarity Therapeutics shares are trading higher after the company announced that its stockholders' equity is significantly above the $2.5 million minimum required by Nasdaq Listing Rule and will submit a request to the SEC to withdraw Form S-1.
Benzinga Newsdesk
-
5 days ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
5 days ago
Allarity Therapeutics Exceeds Nasdaq's Minimum Equity Requirement; Requests Voluntarily Withdrawal Of Form S-1
Benzinga Newsdesk
-
5 days ago
Friday, May 03, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
May 3, 2024, 12:31PM
Thursday, May 02, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
May 2, 2024, 4:31PM
Why Is Nano-Cap Allarity Therapeutics Stock Trading Up On Thursday?
Vandana Singh
-
May 2, 2024, 12:29PM
Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results
Avi Kapoor
-
May 2, 2024, 9:52AM
Market-Moving News May 2nd
Benzinga Newsdesk
-
May 2, 2024, 8:39AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
May 2, 2024, 8:06AM
Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ovarian cancer.
Benzinga Newsdesk
-
May 2, 2024, 8:04AM
Allarity Therapeutics Announces Stenoparib Shows Clear Clinical Benefit, Co. Announces Early Conclusion Of Phase 2 Trial In Advanced Ovarian Cancer
Benzinga Newsdesk
-
May 2, 2024, 8:03AM
Monday, April 29, 2024
Allarity Regains Compliance With NASDAQ Minimum Bid Price Requirement
Benzinga Newsdesk
-
Apr 29, 2024, 7:01AM
Monday, April 22, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Apr 22, 2024, 4:31PM
Thursday, April 18, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Apr 18, 2024, 4:31PM
Wednesday, April 17, 2024
Allarity Therapeutics Receives Extension To Regain Compliance With Nasdaq
Benzinga Newsdesk
-
Apr 17, 2024, 9:11AM
Monday, April 15, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Apr 15, 2024, 8:07AM
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 15, 2024, 5:45AM
Friday, April 12, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Apr 12, 2024, 4:31PM
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Apr 12, 2024, 2:47PM
Allarity Therapeutics Inc Files Prospectus Supplement To Increase Offering Price Of Common Stock That May Be Offered From $2.35M To $3.2M
Benzinga Newsdesk
-
Apr 12, 2024, 2:27PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Apr 12, 2024, 12:31PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Apr 12, 2024, 8:09AM
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 12, 2024, 5:32AM
Thursday, April 11, 2024
Allarity Therapeutics Files Prospectus Supplement To Increase Offering Price Of Common Stock That May Be Offered From $1.4M-$2.4M
Benzinga Newsdesk
-
Apr 11, 2024, 1:42PM
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 11, 2024, 6:14AM
Tuesday, April 09, 2024
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk
-
Apr 9, 2024, 8:55AM
Monday, April 08, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Apr 8, 2024, 7:50PM
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 8, 2024, 5:15AM
Friday, April 05, 2024
Why Reliance Global Group Shares Are Trading Lower By Around 11%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 5, 2024, 5:45AM
Thursday, April 04, 2024
Allarity Therapeutics shares are trading higher. The company announced a 1-for-20 reverse stock split.
Benzinga Newsdesk
-
Apr 4, 2024, 9:29AM
Allarity Therapeutics Announces 1-For-20 Reverse Stock Split Effective April 9, 2024
Benzinga Newsdesk
-
Apr 4, 2024, 9:15AM
Wednesday, March 27, 2024
Allarity Therapeutics Announces Strategic Pivot To Focus Solely On Accelerating Stenoparib Toward Regulatory Approval; IXEMPRA And Dovitinib Development De-Prioritized
Benzinga Newsdesk
-
Mar 27, 2024, 8:33AM
Monday, March 25, 2024
Allarity Therapeutics Has Been Granted A Formal Extension Until April 24, 2024 To Regain Compliance Under Nasdaq Listing Rules
Benzinga Newsdesk
-
Mar 25, 2024, 7:50AM
Wednesday, March 20, 2024
Allarity Therapeutics Entered Into At-The-Market Issuance Sales Agreement With Ascendiant Capital, May Offer Up To $947K In Shares -8-K
Charles Gross
-
Mar 20, 2024, 6:09AM
Friday, March 08, 2024
Allarity Therapeutics: Q4 Earnings Insights
Benzinga Insights
-
Mar 8, 2024, 9:15AM
Allarity Therapeutics FY Net loss Of $(11.9)M Compared To $(16.1)M YoY
Benzinga Newsdesk
-
Mar 8, 2024, 7:21AM
Thursday, February 01, 2024
Allarity Therapeutics Said on Jan 26 Received Notice From Novartis to Terminate Agreement That Provided Co With the Right to Dovitinib Based on Material Breach for Lack of Financial Payment
Charles Gross
-
Feb 1, 2024, 4:52PM
Thursday, December 14, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 14, 2023, 4:31PM
Monday, December 11, 2023
Allarity Therapeutics Said On December 8, 2023, James Cullem Was Terminated As CEO Of Allarity Therapeutics; Thomas Jensen Named New CEO
Charles Gross
-
Dec 11, 2023, 6:33AM
Friday, December 08, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Dec 8, 2023, 12:31PM
Wednesday, December 06, 2023
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Dec 6, 2023, 2:43PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Dec 6, 2023, 12:31PM
Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Dec 6, 2023, 8:32AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Dec 6, 2023, 8:06AM
Tuesday, December 05, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Dec 5, 2023, 4:31PM
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Dec 5, 2023, 1:06PM
Dow Falls 100 Points; ISM Services PMI Increases In November
Lisa Levin
-
Dec 5, 2023, 12:11PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch